INNATUS

Incysus Therapeutics, Inc.

Application Filed: 2020-07-10
Trademark Application Details
Trademark Logo INNATUS

Mark For: INNATUS™ trademark registration is intended to cover the categories of pharmaceutical preparations, namely, oncological preparations; Reagents, diagnostics and therapeutic preparations for medical use in oncology; Targeted medical preparations for use in oncology; Pharmaceutical preparations for use in the treatment of cancer and tumors; Pharmaceutical and medicinal preparations for the treatment of cancer and oncological conditions; Pharmaceutical and biological preparations for use in immunotherapies to improve immune system function; Pharmaceutical and biological preparations combining immunotherapies and chemotherapies for treatments in the field of oncology; Medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of immunological and oncological diseases and disorders; Pharmaceutical and biological preparations comprised of modified T cells used for multiple modes of treatment against tumor resistance and immunosuppression. [all]

Status

2021-10-04 UTC
DEAD APPLICATION Refused Dismissed or Invalidated
This trademark application was refused, dismissed, or invalidated by the Office and this application is no longer active.


Research OneLook Acronym Finder
Serial Number90047593
Mark Literal ElementsINNATUS
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK. SERVICE MARK
RegisterPRINCIPAL
Current LocationTMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED 2021-05-07
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameMark Jansen
Attorney Docket Number37070-00070

Timeline

2020-07-10Application Filed
2020-07-14Location: NEW APPLICATION PROCESSING
2020-07-14Status: Live/Pending
2020-07-14Transaction Date
2021-05-07Location: TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED
2021-05-07Status: Abandoned because the applicant failed to respond or filed a late response to an Office action. To view all documents in this fi

Trademark Parties (Applicants & Owners)

Party: Incysus Therapeutics, Inc.
Address79 Madison Avenue New York, NEW YORK UNITED STATES 10001
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

ApplicationMULTI2020-07-10
DrawingJPEG2020-07-10
Offc Action OutgoingXML2020-10-20
XSearch Search SummaryXML2020-10-20
Notice of AbandonmentXML2021-05-07

Attorney of Record

MARK JANSEN
FENWICK & WEST LLP
801 CALIFORNIA STREET
MOUNTAIN VIEW, CA 94041

Good, Services, and Codes

(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations, namely, oncological preparations; Reagents, diagnostics and therapeutic preparations for medical use in oncology; Targeted medical preparations for use in oncology; Pharmaceutical preparations for use in the treatment of cancer and tumors; Pharmaceutical and medicinal preparations for the treatment of cancer and oncological conditions; Pharmaceutical and biological preparations for use in immunotherapies to improve immune system function; Pharmaceutical and biological preparations combining immunotherapies and chemotherapies for treatments in the field of oncology; Medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of immunological and oncological diseases and disorders; Pharmaceutical and biological preparations comprised of modified T cells used for multiple modes of treatment against tumor resistance and immunosuppression(ABANDONED)
IC 042. US 100 101. G & S: Research, development, and evaluation of new products; Pharmaceutical, medicine, and vaccine research and development services; Technical research in the field of pharmaceutical studies; Laboratory analysis and research into new drugs and pharmaceutical products; Development of measuring and testing methods in the field of medicine; Design, development, research, and testing of drugs and pharmaceuticals for the treatment and/or prevention of cancer; Research and development services in the fields of oncology, immunotherapy, chemotherapy and combination therapies for the treatment of cancer and tumors; Providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; Scientific advisory services, namely, providing scientific information, advice and consultancy in the field of oncology

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:42
U.S. Codes:100,101
Type CodeType
GS0051Pharmaceutical preparations, namely oncological preparations; Reagents, diagnostics and therapeutic preparations for medical use in oncology; Targeted medical preparations for use in oncology; Pharmaceutical preparations for use in the treatment of cancer and tumors; Pharmaceutical and medicinal preparations for the treatment of cancer and oncological conditions; Pharmaceutical and biological preparations for use in immunotherapies to improve immune system function; Pharmaceutical and biological preparations combining immunotherapies and chemotherapies for treatments in the field of oncology; Medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of immunological and oncological diseases and disorders; Pharmaceutical and biological preparations comprised of modified T cells used for multiple modes of treatment against tumor resistance and immunosuppression

Trademark Filing History

DescriptionDateProceeding Number
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND2021-05-07
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE2021-05-07
NOTIFICATION OF NON-FINAL ACTION E-MAILED2020-10-206325
NON-FINAL ACTION WRITTEN2020-10-2068792
NON-FINAL ACTION E-MAILED2020-10-206325
ASSIGNED TO EXAMINER2020-10-2068792
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2020-08-07
NEW APPLICATION ENTERED IN TRAM2020-07-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed